"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Ruan Neurology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ruan Neurology" are "Acute Ischemic Stroke" (1 trials), "Alzheimer Disease" (1 trials), "Cryptogenic Stroke" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Ruan Neurology" in a lesser frequency.

Most popular intervention types in "Ruan Neurology" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMPLATZER PFO Occluder" (1 trials), "Fingolimod" (1 trials), "Placebo" (1 trials), "Standard of Care - Medical Management" (1 trials) and "alfimeprase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ruan Neurology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ruan Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ruan Neurology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ruan Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".